Monday, January 21, 2013

ZIV Starting to Gain Momentum

One year ago, I wrote ZIV Undeservedly Neglected when ZIV was trading about 5,000 shares per day and was not even on the radar of many investors who follow the VIX exchange-traded products space. In the land of inverse VIX-based ETPs, it seemed as if XIV was destined to grab all the headlines and the glory, with ZIV relegated to distant also-ran status. Frankly, I was somewhat concerned that ZIV was an ETP with a great deal of potential that might be shuttered due to neglect long before mainstream investors had an opportunity to discover its charms.

One year later, ZIV is still struggling to find adherents, trading approximately 60,000 shares per day as of late, while its performance has become even more difficult to ignore. Over the past year, ZIV is up 103%; and during that period it had a maximum drawdown of only 19%, as the graphic below illustrates. Of course, one can never cut and paste past performance into the future with any degree of certainty, but the record over the course of the past year points toward the potential of ZIV, neglected or otherwise.

[source(s): ETFreplay.com]

A year ago, I summarized some of my thinking on ZIV as follows:

“I am frankly surprised by the lack of interest investors have shown in ZIV, the VelocityShares Daily Inverse VIX Medium-Term ETN. In a nutshell, ZIV has many of the same benefits of long XIV and/or short VXX positions, with much less risk. Specifically, ZIV benefits from negative roll yield about 65% of the time, with VIX futures data going back to 2004 indicating that the annual benefit due to negative roll averages out at more than 20% per year. With XIV getting all the attention, I wonder if investors are aware that XIV is down and ZIV is up since the two products were launched.

Of course, like XIV, ZIV is exposed to sharp spikes in the VIX, as the chart below reflects. It is worth noting, however, that when the VIX spikes, ZIV can be expected to lose value at about half the rate of losses in XIV. For example, while XIV was falling 75%, ZIV was down 42%.  It bears repeating that one of the key features of inverse volatility products is that the potential for large short-term losses is significant, even though the long-term prospects are promising.”

Going forward, ZIV is going to have to make it or break it on its own merits, but for those few who have enjoyed the ride for the past year, it is clear that the potential is enormous – at least under certain market environments.

Related posts:

Disclosure(s): long XIV and ZIV, short VXX at time of writing

blog comments powered by Disqus
DISCLAIMER: "VIX®" is a trademark of Chicago Board Options Exchange, Incorporated. Chicago Board Options Exchange, Incorporated is not affiliated with this website or this website's owner's or operators. CBOE assumes no responsibility for the accuracy or completeness or any other aspect of any content posted on this website by its operator or any third party. All content on this site is provided for informational and entertainment purposes only and is not intended as advice to buy or sell any securities. Stocks are difficult to trade; options are even harder. When it comes to VIX derivatives, don't fall into the trap of thinking that just because you can ride a horse, you can ride an alligator. Please do your own homework and accept full responsibility for any investment decisions you make. No content on this site can be used for commercial purposes without the prior written permission of the author. Copyright © 2007-2013 Bill Luby. All rights reserved.
 
Web Analytics